CG Oncology, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2023 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
CG Oncology, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2023 to Q4 2024.
  • CG Oncology, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2024 was $221K, a 47.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $221K -$201K -47.6% Dec 31, 2024 10-K 2025-03-28
Q3 2024 $275K Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $329K Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $368K Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $422K Dec 31, 2023 10-K 2025-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.